• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Editorial: Cellular immunotherapy: transforming cancer treatment

14 de November de 2025
Front Immunol. 2025 Oct 29;16:1724025. doi: 10.3389/fimmu.2025.1724025.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-11-14 11:00:002025-11-14 11:00:00Editorial: Cellular immunotherapy: transforming cancer treatment

Humanized mouse models in MDS

17 de July de 2025
Cell Death Dis. 2025 Jul 17;16(1):531. doi: 10.1038/s41419-025-07861-0.ABSTRACTMyelodysplastic…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-07-17 10:00:002025-07-17 10:00:00Humanized mouse models in MDS

BET inhibitors down-regulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1

26 de September de 2024
Haematologica. 2024 Sep 26. doi: 10.3324/haematol.2024.285966.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-09-26 10:00:002024-09-26 10:00:00BET inhibitors down-regulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1

NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models

18 de January de 2024
Methods Mol Biol. 2024;2773:9-24. doi: 10.1007/978-1-0716-3714-2_2.ABSTRACTT-cell…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-01-18 11:00:002024-01-18 11:00:00NOTCH1-Induced T-Cell Acute Lymphoblastic Leukemia In Vivo Models

Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia

10 de March de 2022
Cancers (Basel). 2022 Mar 4;14(5):1335. doi: 10.3390/cancers14051335.ABSTRACTJuvenile…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-03-10 11:00:002022-03-10 11:00:00Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia

Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL

12 de January de 2022
Blood. 2022 Apr 21;139(16):2483-2498. doi: 10.1182/blood.2021012077.ABSTRACTNOTCH1…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-01-12 11:00:002022-01-12 11:00:00Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL

Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma

29 de August de 2021
Leukemia. 2022 Feb;36(2):583-587. doi: 10.1038/s41375-021-01389-w.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-08-29 10:00:002021-08-29 10:00:00Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma

Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia

16 de April de 2021
Trends Immunol. 2021 May;42(5):418-431. doi: 10.1016/j.it.2021.03.005.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-04-16 10:00:002021-04-16 10:00:00Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia

Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia

2 de April de 2021
Nat Cancer. 2020 Nov;1(11):1113-1127. doi: 10.1038/s43018-020-00124-1.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-04-02 10:00:002021-04-02 10:00:00Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia

Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma

28 de December de 2020
PLoS Genet. 2020 Dec 23;16(12):e1008960. doi: 10.1371/journal.pgen.1008960.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-12-28 11:00:002020-12-28 11:00:00Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma

The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia

2 de October de 2019
Cold Spring Harb Perspect Med. 2020 Mar 2;10(3):a035246. doi:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-10-02 10:00:002019-10-02 10:00:00The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia

GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia

15 de September de 2019
Cancer Discov. 2019 Dec;9(12):1774-1791. doi: 10.1158/2159-8290.CD-19-0471.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-09-15 10:00:002019-09-15 10:00:00GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia
Page 1 of 3123

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}